Myocardial viability assessment is indicated in patients with severe coronary artery disease
(CAD) and severe left ventricular (LV) dysfunction (Table 1)[1-10]. In many other patients …

The assessment of myocardial viability has gained a lot of attention over the past few years.
Various imaging techniques, mainly nuclear and echocardiographic approaches, have been …

During the past decade there has been intense interest in the study of myocardial viability
and its relevance to patient treatment and outcome. This article reviews current concepts …

Heart failure is an emerging worldwide epidemic. In the USA alone, there are an estimated
4.8 million Americans with heart failure, 10% of persons aged 70 years or greater and …

Over the past decade it has become clear that chronic left ventricular dysfunction is not
necessarily an irreversible process [1-41. In some patients recovery of function may occur …

Although the death rate from coronary artery disease has decreased over the past 20 years,
the incidence of congestive heart failure (CHF) has increased. The most common cause of …

Although major advances have occurred lately in medical therapy, ischemic heart failure
remains an important cause of death and disability. Viable myocardium represents a cause …

The number of patients with ischemic cardiomyopathy has increased extensively over recent
years. Therapies include medical treatment, cardiac transplantation, cardiac …

In this paper, some controversial points regarding myocardial its definition hibernation are
discussed, including its definition (improvement in contractility versus improvement in …

Objectives: This study pools data from published series examining late survival with
revascularization versus medical therapy after myocardial viability testing in patients with …